Akira Yokomizo

Harasanshin Hospital, Kyushu University

Papers

2

Total Citations

10

H-Index

2

About

Akira Yokomizo is a leading urologic oncologist whose research focuses on optimizing treatment strategies for prostate cancer, with a particular emphasis on cost-effectiveness and minimally invasive surgical techniques. His most impactful work stems from the PRIAS-JAPAN study, where he led a critical investigation comparing the medical costs of active surveillance against more aggressive treatments—including robot-assisted laparoscopic prostatectomy, brachytherapy, and hormone therapy—for low-risk prostate cancer. This 2022 study, which has garnered 8 citations, provides essential real-world data demonstrating that active surveillance is a financially sustainable option, helping to shape clinical guidelines and reduce overtreatment in Japan’s healthcare system. Earlier in his career, Yokomizo was a pioneer in robotic-assisted surgery, authoring the 2005 initial case report on laparoscopic radical prostatectomy using the ZEUS robotic system for vesico-urethral anastomosis. This early work, though modestly cited, established a foundation for the robotic surgical techniques now widely adopted. Through his blend of health economics research and surgical innovation, Yokomizo continues to influence both the clinical management and economic sustainability of prostate cancer care.

Research Focus

Key Achievements

2
H-Index
2
Papers
10
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
Comparison of the medical costs between active surveillance and other treatments for early prostate cancer in Japan using data from the PRIAS‐JAPAN study
8 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 23
🏛 Institutions: Harasanshin Hospital, Kyushu University

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago